Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-82,513
Closed -$10.2M 2946
2025
Q2
$9.91M Buy
82,513
+41,637
+102% +$5.56M 0.04% 312
2025
Q1
$6.02M Sell
40,876
-170,046
-81% -$26M 0.04% 372
2024
Q4
$34.3M Buy
210,922
+124,520
+144% +$20.4M 0.18% 72
2024
Q3
$14.1M Buy
+86,402
New +$12.8M 0.07% 181
2023
Q2
Sell
-54,013
Closed -$8.71M 2567
2023
Q1
$8.55M Buy
+54,013
New +$8.1M 0.1% 161
2022
Q3
Sell
-19,332
Closed -$2.79M 2883
2022
Q2
$2.73M Buy
+19,332
New +$2.76M 0.03% 459
2022
Q1
Sell
-2,681
Closed -$467K 3194
2021
Q4
$467K Buy
+2,681
New +$447K ﹤0.01% 1941
2020
Q2
Sell
-6,337
Closed -$1.1M 1559
2020
Q1
$1.1M Buy
+6,337
New +$1.05M 0.07% 236
2019
Q1
Sell
-1,541
Closed -$237K 554
2018
Q4
$237K Buy
+1,541
New +$240K 0.03% 424

Other funds holding CLX

HRT Financial's CLX Position: Q3 2025 in Review

HRT Financial sold out of Clorox (CLX) in Q3 2025, closing a stake of 82,513 shares — an estimated $10.2M sold.

HRT Financial first reported a position in CLX in Q4 2018 and held it in 9 quarters. The position peaked at $34.3M in Q4 2024. 1,091 funds tracked by Wall St. Rank hold CLX as of Q3 2025.

  • HRT Financial reported no remaining Clorox position as of Q3 2025 after selling out during the quarter.
  • HRT Financial sold 82,513 Clorox shares in Q3 2025, an estimated $10.2M.
  • HRT Financial first reported a position in Clorox in Q4 2018 and held it in 9 quarters.
  • HRT Financial's Clorox position peaked at $34.3M in Q4 2024.
  • 1,091 funds tracked by Wall St. Rank held Clorox as of Q3 2025.

Based on HRT Financial's 13F filing for Q3 2025, filed 14 Nov 2025.